Over the Forecast Period, the Medical Sevoflurane Market will register a CAGR of 8.4% in terms of revenue and the global market size will reach USD 1,800 Million by 2029.
Medical Sevoflurane Market Overview
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anaesthesia. After desflurane, it is the fastest-acting volatile anaesthetic.
The increasing number of surgical procedures can be contributed to the market's rise. When compared to intravenous anaesthesia, inhalation anaesthetic allows for better patient outcomes. Controllable and effective sedation can be achieved by administering an anaesthetic drug through the respiratory tract, which is both cost-efficient and safe. The market is primarily driven by the advantages of inhalation anaesthesia over intravenous anaesthesia. For patients who will be on ventilation for longer than 24 hours, inhalation anaesthesia is the best option because it is easier to monitor the patient's health. As a result, better patient benefits associated with inhalation anaesthetic than intravenous anaesthesia are predicted to drive revenue growth during the projection period.
As a result of continual healthcare technology advancements, highly advanced technologies are used every day all around the world. Advances in science and technology have resulted in more effective disease prevention and recovery methods. Given that numerous technical advancements serve various medical sectors, it's no wonder that such improvements frequently produce market ripples. The negative effects of inhalation anaesthetics, on the other hand, represent a major roadblock to the target market's expansion. Lack of awareness, as well as recent patent expirations, will limit the global market's growth in the coming year.
What is our Medical Sevoflurane Market Scope?
|
Report Attributes
|
Report Details
|
|
Forecast Period 2022 to 2029 CAGR
|
CAGR of 8.4%during the review period (2022 to 2029).
|
|
By Type
|
- Generic Drug
- Original Drug
|
|
By Application
|
|
|
By Companies
|
- AneticAid Ltd
- Abbott Laboratories
- Maruishi Pharmaceutical
- Collins Ltd.
- Mylan Seiyaku Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Baxter
- BOC Healthcare
- Abbvie
- Piramal
- Hengrui
- Lunan
- Hikma
|
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
|
Base Year
|
2021
|
|
Historical Year
|
2016 to 2020
|
|
Forecast Year
|
2022-2029
|
|
Number of Pages
|
161
|
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Who are the Major Players in Medical Sevoflurane Market?
The Medical Sevoflurane Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. The main players in this Abbott Laboratories,Maruishi Pharmaceutical,Collins Ltd.Mylan Seiyaku Ltd.,Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,Baxter, BOC Healthcare, Abbvie, Piramal, Hengrui, Lunan, Hikma and Others
Industry News
Allergan Aesthetics, an AbbVie company, and a global leader in medical aesthetics treatments, today launched 'The Future of Aesthetics' global trends report via a high-profile virtual event for media and industry. Commissioned by Allergan Aesthetics and independently developed by specialist trend forecasting agency Wunderman Thompson Intelligence, the report aims to help the industry understand the developments driving today's aesthetics market, and to highlight the key trends that may shape it in the years ahead.
What are the major Applications, Types for Medical Sevoflurane?
By Type, it is segmented into
- Generic Drug
- Original Drug
By Applications it is segmented into
Medical Sevoflurane Market Regional Analysis
The largest market for inhalation anaesthesia is likely to be in North America. The study report focuses on inhalation anaesthesia product business forecasts for Europe, Latin America, Asia-Pacific, North America, the Middle East, and Africa. North America dominates the inhalation anaesthesia market due to the rising prevalence of several chronic conditions, the presence of modern healthcare facilities, and the presence of prominent firms in the region. The business plans that are implemented by the major companies in the countries will also contribute to the expansion of North America. Due to rising demand for inhalation anaesthesia in the end-use industry, Asia Pacific is expected to register a significant . Similarly, the majority of the market's businesses are making significant strides in order to stay competitive. • North America (the United States, Canada, and Mexico)
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
-
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- INTRODUCTION
- MARKET DEFINATION
- MARKET DYNAMICS
- MARKET SEGMENTATION
- REPORT TIMELINES
- KEY STAKEHOLDERS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT MATTER EXPERT ADVICE
- QUALITY CHECK
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- EXECUTIVE SUMMARY
- INTRODUCTION
- GLOBAL MEDICAL SEVOFLURANE BY TYPES
- GLOBAL MEDICAL SEVOFLURANE BY APPLICATIONS
- MARKET DYNAMICS
- DRIVERS
- INCREASING DEMAND FOR MEDICAL SEVOFLURANE
- STRINGENT ENVIRONMENTAL REGULATIONS
- HIGH COST ON MATERIALS
- OPPORTUNITIES
- CASIMERSEN GROWTH
- APPLICATION OF MEDICAL SEVOFLURANE
- IMPACT OF COVID 19
- GLOBAL MEDICAL SEVOFLURANE MARKET, BY TYPES
- INTRODUCTION
- GENERIC DRUG
- ORIGINAL DRUG
- GLOBAL MEDICAL SEVOFLURANE MARKET, BY APPLICATION
- INTRODUCTION
- CHILDREN
- ADULTS
- GLOBAL MEDICAL SEVOFLURANE MARKET, BY REGION
- NORTH AMERICA
- EUROPE
- GERMANY
- FRANCE
- UK
- ITALY
- RUSSIA
- REST OF EUROPE
- APAC
- CHINA
- SOUTH KOREA
- JAPAN
- INDIA
- AUSTRALIA
- ASEAN
- REST OF APAC
- MIDDLE EAST AND AFRICA
- SAUDI ARABIA
- UAE
- SOUTH AFRICA
- TURKEY
- REST OF MEA
- SOUTH AMERICA
- BRAZIL
- REST OF MEA
- ARGENTINA
- REST OF SOUTH AMERICA
- COMPETITIVE LANDSCAPE
- MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
- AND AGREEMENTS
- MARKET SHARE PERCENT RANKING ANALYSIS
- STRATEGIES ADOPTED BY LEADING PLAYERS
- COMPANY PROFILES
- BUSINESS OVERVIEW
- COMPANY SNAPSHOT
- PRODUCT BENCHMARKING
- STRATEGIC INITIATIVES
- ABBOTT LABORATORIES
- MARUISHI PHARMACEUTICAL
- COLLINS LTD.
- MYLAN SEIYAKU LTD.
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
- BAXTER
- BOC HEALTHCARE
- ABBVIE
- PIRAMAL
- HENGRUI
- LUNAN
- HIKMA
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
